Search Results for: Angiotensin-Converting Enzyme 2

January 6, 2025January 6, 2025

Binding ability of Delta and Omicron towards the angiotensin-converting enzyme 2 receptor and antibodies: a computational study.

Publication date: Jan 05, 2025 The COVID-19 pandemic posed a threat to global society. Delta and Omicron are concerning variants due to the risk of increasing human-to-human transmissibility and immune ... Read more

December 20, 2024December 20, 2024

Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2.

Coronavirus Literature

Publication date: Dec 13, 2024 For the prevention of SARS-CoV-2 infection, four Fv-antibodies with binding affinity for the ACE2 receptor were screened from an Fv-antibody library. The screened Fv-antibodies were ... Read more

November 29, 2024November 29, 2024

SARS-CoV-2 Genomic Variants and Their Relationship with the Expressional and Genomic Profile of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2).

Coronavirus Literature

Publication date: Nov 14, 2024 Over the past four years, angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) have been extensively studied, given their important role in SARS-CoV-2 ... Read more

November 29, 2024November 29, 2024

SARS-CoV-2 Genomic Variants and Their Relationship with the Expressional and Genomic Profile of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2).

Coronavirus Literature

November 29, 2024November 29, 2024

Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2.

Coronavirus Literature

Publication date: Nov 16, 2024 The mutational drift of SARS-CoV-2 and the appearance of multiple variants, including the latest Omicron variant and its sub-lineages, has significantly reduced (and in some ... Read more

November 29, 2024November 29, 2024

Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2.

Coronavirus Literature

November 29, 2024November 29, 2024

SARS-CoV-2 Genomic Variants and Their Relationship with the Expressional and Genomic Profile of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2).

Coronavirus Literature

November 29, 2024November 29, 2024

Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2.

Coronavirus Literature

November 9, 2024November 9, 2024

Evaluation of Angiotensin-Converting Enzyme 2 Expression In Vivo with Novel Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain.

Coronavirus Literature

Publication date: Oct 11, 2024 Angiotensin-converting enzyme 2 (ACE2) is not only a key to the renin-angiotensin-aldosterone system and related diseases, but also the main entry point on cell surfaces ... Read more

November 29, 2024November 29, 2024

Rabbit and Human Angiotensin-Converting Enzyme-2: Structure and Electric Properties.

Coronavirus Literature

Publication date: Nov 19, 2024 The angiotensin-converting enzyme-2 (ACE2) is a transmembrane glycoprotein, consisting of two segments: a large carboxypeptidase catalytic domain and a small transmembrane collectrin-like segment. This protein ... Read more